Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$269,776,838
-$73,411,004 QoQ
Shares Held
4,682,000
-17.3% QoQ
Ownership
0.229%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#58
of 2,514 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 43%
Shared 0%
None 57%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Derivatives in BMY
reported options exposure · as of Jun 30, 2026CallValue
$345,720
CallShares
6,000
PutValue
$345,720
PutShares
6,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Man Group plc holds $1,927,079,072 across 11 Drug Manufacturers - General names. BMY ranks #3 (14.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
398,861 | $478,405,888 | |
| 2 | ABBV |
AbbVie Inc.
|
1,704,016 | $428,798,585 | |
| 3 | BMY |
Bristol Myers Squibb Co
This page
|
4,682,000 | $269,776,838 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,235,196 | $156,054,661 | |
| 5 | JNJ |
Johnson & Johnson
|
517,830 | $131,513,284 | |
| 6 | AZN |
Astrazeneca PLC
|
683,112 | $129,531,696 | |
| 7 | MRK |
Merck & Co., Inc.
|
990,469 | $127,275,266 | |
| 8 | AMGN |
Amgen Inc
|
234,023 | $84,744,407 |
All Filings in BMY
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $345,720 | 6,000 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $345,720 | 6,000 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $269,776,838 | 4,682,000 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $343,187,842 | 5,658,497 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $909,750 | 15,000 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $909,750 | 15,000 | Put | Defined | 2026-05-15 | |
| 2025-12-31 | $809,100 | 15,000 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $448,647,999 | 8,317,538 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $809,100 | 15,000 | Put | Defined | 2026-02-17 | |
| 2025-09-30 | $416,190,015 | 9,228,160 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $345,593,964 | 7,465,845 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $119,690,067 | 1,962,454 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $97,742,862 | 1,728,127 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $167,120,819 | 3,230,012 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $194,729,932 | 4,688,898 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $99,058,251 | 1,826,632 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $112,598,511 | 2,194,475 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $15,440,495 | 266,032 | Principal | Defined | 2023-11-14 | |
| 2023-06-30 | $33,181,862 | 518,872 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $32,430,841 | 467,910 | Principal | Defined | 2023-05-15 | |
| 2022-12-31 | $58,708,680 | 815,965 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $43,429,590 | 610,910 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $25,082,211 | 325,743 | Principal | Defined | 2022-08-15 | |
| 2022-03-31 | $16,057,980 | 219,882 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $41,727,050 | 669,239 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $75,209,861 | 1,271,081 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $55,691,727 | 833,459 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $122,635,136 | 1,942,581 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $208,938,004 | 3,368,338 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $250,098,835 | 4,148,264 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $209,589,777 | 3,564,452 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $63,364,449 | 1,136,786 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||